Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) shares moved down -0.28% in last trading session and ended the day at $3.55. CNAT has a return on assets of -58.40%. Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) quarterly performance is -15.68%.
Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) announced that abstracts for two posters addressing preclinical results with the company’s pan-caspase inhibitors, have been accepted for presentation at The Liver Meeting®, the annual meeting of the American Association for the Study of Liver Diseases (AASLD) in San Francisco November 13-17, 2015.
The Coca-Cola Company (NYSE:KO) ended the last trading day at $41.38. Company weekly volatility is calculated as 0.97% and price to cash ratio as 7.90. The Coca-Cola Company (NYSE:KO) showed a weekly performance of -1.38%.
The Coca-Cola Company (NYSE:KO) declared a cash dividend of $0.3300 on Oct 15, 2015. The shares will quote ex-dividend on Nov 27, 2015 and the record date has been fixed on Dec 1, 2015. At Oct 15, 2015 share price, the yield comes out to be 3.1670%. The dividend payable date has been fixed on Dec 15, 2015.
On 13 November, Alcatel Lucent SA (ADR) (NYSE:ALU) shares moved down -2.03% and was closed at $3.86. ALU EPS growth in last 5 year was 28.00%. Alcatel Lucent SA (ADR) (NYSE:ALU) year to date (YTD)
performance is 8.73%.
On 5 November, Alcatel Lucent SA (ADR) (NYSE:ALU) has started the commercial deployment of residential multi-standard small cell devices. Alcatel-Lucent did not reveal additional details on the deployment of the small cells and locations or telecom operator clients.
Eros International Plc (NYSE:EROS) shares moved down -20.45% in last trading session and ended the day at $7.08. EROS Gross Margin is 46.20% and its has a return on assets of 4.00%. Eros International Plc (NYSE:EROS) quarterly performance is -80.58%.
Eros International Plc (NYSE:EROS) announced that the annual meeting of its shareholders will be held on Tuesday, December 1, 2015, beginning at 11:00 AM, Greenwich Mean Time (GMT), at Fort Anne, Douglas, Isle of Man IM1 5PD, British Isles. The Company’s notice of annual meeting and form of proxy were issued on October 15, 2015.
PTC Therapeutics, Inc. (NASDAQ:PTCT) caters to the Healthcare space. Its weekly performance is 7.76%. On the last day of trading company shares ended up at $30.27. PTC Therapeutics, Inc. (NASDAQ:PTCT) distance from 50-day simple moving average (SMA50) is -3.84%.
On 2 November, PTC Therapeutics, Inc. (NASDAQ:PTCT) said that, it provides an overview of the PTC Therapeutics, Inc.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of PTC Therapeutics, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
Leave a Reply